A Nature research paper reports Phase II clinical results of PI3Kδ inhibition in solid tumors, and the exploration of immune adverse events
We thank C. Rommel, K. Ali, P. Johnson and D. Scott for support and help during the initial phases of setting up the CRUK/Amgen collaboration; F. Martin for project support over the years; M. Lopez and the research pathology core at University Hospital Southampton for performing the immunohistochemistry on the paraffin embedded material; I.
Lindsey Chudley, Joseph J. Sacco, Andrew Graeme Schache, Richard Shaw, Terry M. Jones, Pandurangan Vijayanand & Christian H. Ottensmeier Department of Otorhinolaryngology, Head and Neck Surgery, Ulm University Medical Center, Ulm, GermanyElena Lopez-Guadamillas & Bart VanhaesebroeckNicola A.
Norge Siste Nytt, Norge Overskrifter
Similar News:Du kan også lese nyheter som ligner på denne som vi har samlet inn fra andre nyhetskilder.
Projected environmental benefits of replacing beef with microbial protein - NatureReplacing 20% of per-capita ruminant consumption with microbial protein can offset future increases in global pasture area, cut annual deforestation and related CO2 emissions in half, and lower methane emissions.
Les mer »
Nature is trialling transparent peer review — the early results are encouragingLast year, nearly half of Nature authors agreed to publish anonymous referee reports. We hope that more will consider doing so this year.
Les mer »
Hawaii Volcano Lava Flow Steady After Starts And StopsKilauea Volcano is now erupting a steady stream of lava after a period of intermittent pulsing.
Les mer »
Federal Reserve spikes interest rate to curb inflationThe Federal Reserve has raised its benchmark short-term interest rate by a half-percentage point - the largest rate hike since 2000 - and is expected to follow up with the fastest pace of hikes in 30 years.
Les mer »
Astonishing Heat Grips India and PakistanSustained temperatures above 110 degrees Fahrenheit threaten people, wheat crops and power supplies
Les mer »